Search research articles
Contact Us
Filters
Showing results (301-310 of 352) with videos related to
Page
of 36
Sort By:
Gynecologic Oncology
|
August 22, 2018
Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma
Ting-Tai Yen, Tsutomu Miyamoto, Shiho Asaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
HLA-G is a potential tumor marker in malignant ascites
Gad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical and Translational Medicine
|
July 31, 2024
Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer
Christine M O'Keefe, Yang Zhao, Leslie M Cope, et al.
Cancer Research
|
June 6, 2012
Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis
Yi Zhang, Yan Cheng, Xingcong Ren, et al.
Journal of Biomedical Optics
|
July 3, 2021
Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes
Ricky Cordova, Kelli Kiekens, Susan Burrell, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Integrated Spatial Analysis of Ovarian Precancerous Lesions
Tu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
<i>HIST1H2BB</i> and <i>MAGI2</i> Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer
Blanca L Valle, Sebastian Rodriguez-Torres, Elisabetta Kuhn, et al.
The American Journal of Surgical Pathology
|
September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility
Natalie Banet, Allen M Gown, Ie-Ming Shih, et al.
The Journal of Pathology
|
March 22, 2014
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
Cheryl A Sherman-Baust, Elisabetta Kuhn, Blanca L Valle, et al.
Cell Reports
|
March 29, 2018
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
Takeshi Fukumoto, Pyoung Hwa Park, Shuai Wu, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 352) with videos related to
Sort By:
Page
of 36
Gynecologic Oncology
|
August 22, 2018
Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma
Ting-Tai Yen, Tsutomu Miyamoto, Shiho Asaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
HLA-G is a potential tumor marker in malignant ascites
Gad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Clinical and Translational Medicine
|
July 31, 2024
Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer
Christine M O'Keefe, Yang Zhao, Leslie M Cope, et al.
Cancer Research
|
June 6, 2012
Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis
Yi Zhang, Yan Cheng, Xingcong Ren, et al.
Journal of Biomedical Optics
|
July 3, 2021
Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes
Ricky Cordova, Kelli Kiekens, Susan Burrell, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Integrated Spatial Analysis of Ovarian Precancerous Lesions
Tu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 26, 2020
<i>HIST1H2BB</i> and <i>MAGI2</i> Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer
Blanca L Valle, Sebastian Rodriguez-Torres, Elisabetta Kuhn, et al.
The American Journal of Surgical Pathology
|
September 5, 2014
GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility
Natalie Banet, Allen M Gown, Ie-Ming Shih, et al.
The Journal of Pathology
|
March 22, 2014
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
Cheryl A Sherman-Baust, Elisabetta Kuhn, Blanca L Valle, et al.
Cell Reports
|
March 29, 2018
Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer
Takeshi Fukumoto, Pyoung Hwa Park, Shuai Wu, et al.
Page
of 36